Oskar Vilhelmsson Timmermand
31 – 34 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2014
-
Mark
In vivo evaluation of 177Lu-labeled h11B6, a humanized antibody for hK2 targeting in prostate cancer
Vilhelmsson Timmermand, Oskar LU
; Larsson, Erik
LU
; Strand, Sven-Erik
LU
and Tran, Thuy
LU
(2014)
In Journal of Nuclear Medicine
55(Supplement 1).
- Contribution to journal › Published meeting abstract
-
Mark
Combining optical Cherenkov luminescence imaging and SPECT for intratherapy dosimetry in preclinical radionuclide therapy
Axelsson, Johan LU ; Vilhelmsson Timmermand, Oskar LU
; Mellhammar, Emma
LU
and Tran, Thuy
LU
(2014)
In Journal of Nuclear Medicine
55(Supplement 1).
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Preclinical radioimmunotherapy of prostate cancer with 177Lu-11B6, a 177Lu-labeled monoclonal antibody specifically targeting free, unbound human kallikrein-related peptidase 2
Vilhelmsson Timmermand, Oskar LU
; Tran, Thuy
LU
; Larsson, Erik
LU
; Pettersson, Kim
; Lilja, Hans Gösta
LU
; Ulmert, David
LU
and Strand, Sven-Erik
LU
(2013)
In Journal of Nuclear Medicine
54(Supplement 2).
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Targeting the human kallikrein-2 (hK2) expression in prostate cancer using 111In-labelled monoclonal antibody 11B6
Tran, Thuy LU ; Vilhelmsson Timmermand, Oskar LU
; Evans Axelsson, Susan
LU
; Pettersson, Kim
; Bjartell, Anders
; Lilja, Hans
; Ulmert, David
LU
and Strand, Sven-Erik
LU
(2012)
In Journal of Nuclear Medicine
53(Suppl. 1).
p.1102-1102
- Contribution to journal › Published meeting abstract
- « previous
- 1
- 2
- 3
- 4
- next »